Uric acid level may not be reduced in essential tremor

Area of Science:

• Neurology
• Biochemistry

Background:

• Essential tremor (ET) is a common neurological disorder with heterogeneous characteristics, making neuropathological studies challenging.
• Inconsistent pathological findings in ET highlight the need for reliable biomarkers.
• Uric acid, a potent antioxidant, is being investigated as a potential biomarker in neurodegenerative diseases.

Purpose of the Study:

• To investigate whether uric acid levels are reduced in essential tremor patients compared to healthy individuals.
• To explore the potential of uric acid as a biomarker for essential tremor, particularly in relation to neurodegeneration.

Main Methods:

• A prospective, case-control, multicenter study involving 92 essential tremor patients and 77 healthy subjects.
• Essential tremor patients were categorized into hereditary and sporadic subgroups for detailed analysis.
• Clinical and laboratory findings, including uric acid and total cholesterol levels, were compared across groups.

Main Results:

• Uric acid levels were lower in the essential tremor group but did not reach statistical significance.
• A negative correlation was observed between uric acid levels and disease duration in hereditary ET.
• Uric acid levels negatively correlated with age at onset in sporadic ET, and total cholesterol levels differed significantly between sporadic ET and other groups.

Conclusions:

• The study found no significant evidence to support uric acid levels as an indicator of essential tremor being a neurodegenerative disease.
• Negative correlations between uric acid levels and disease duration/age at onset warrant further investigation in larger cohorts.
• Additional research with larger sample sizes may clarify the role of uric acid in essential tremor pathophysiology.